CANF

Can-Fite BioPharma

11 hedge funds and large institutions have $1.62M invested in Can-Fite BioPharma in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AC
1
Armistice Capital
New York
$1.34M 518,853 +136,055 +36%
Morgan Stanley
2
Morgan Stanley
New York
$175K 67,807 +12,000 +22%
RhumbLine Advisers
3
RhumbLine Advisers
Massachusetts
$39.7K 15,398 -3,084 -17%
VF
4
Virtu Financial
New York
$27K 10,417 +10,417 New
HF
5
HRT Financial
New York
$27K 10,790 +10,790 New
Fifth Third Bancorp
6
Fifth Third Bancorp
Ohio
$7.74K 3,000
National Bank of Canada
7
National Bank of Canada
Quebec, Canada
$1.55K 600
Citigroup
8
Citigroup
New York
$1.43K 553
AWM
9
Activest Wealth Management
Florida
$516 200 +200 New
Osaic Holdings
10
Osaic Holdings
Arizona
$477 185 +185 New
TWC
11
TD Waterhouse Canada
Ontario, Canada
$52 20 +20 New
Citadel Advisors
12
Citadel Advisors
Florida
-14,171 Closed
UBS Group
13
UBS Group
Switzerland
-2,172 Closed
CFGS
14
Concourse Financial Group Securities
Alabama